Latest news
25 items- 13D/GAmendment: SEC Form SC 13G/A filed by Churchill Capital Corp VIISC 13G/A - Churchill Capital Corp VII (0001828248) (Subject)
- SECSEC Form 15-12G filed by Churchill Capital Corp VII15-12G - Churchill Capital Corp VII (0001828248) (Filer)
- INSIDERLarge owner Magnetar Financial Llc disposed of $90,084,438 worth of shares (8,306,005 units at $10.85) (SEC Form 4)4 - Churchill Capital Corp VII (0001828248) (Issuer)
- SECChurchill Capital Corp VII filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form 25-NSE filed by Churchill Capital Corp VII25-NSE - Churchill Capital Corp VII (0001828248) (Subject)
- PRChurchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business CombinationChurchill Announces Redemption of Public Shares NEW YORK and ALTRINCHAM, England, Aug. 18, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill") (NASDAQ:CVII), a publicly-traded special purpose acquisition company, and CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, today announced that they have mutually agreed to terminate their previously announced merger agreement (the "Merger Agreement") due to IPO market conditions, effective today. "While market conditions are not favorab
- SECSEC Form 10-Q filed by Churchill Capital Corp VII10-Q - Churchill Capital Corp VII (0001828248) (Filer)
- SECChurchill Capital Corp VII filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- PRRedemption Deadline for Churchill VII stockholders extended until August 9, 2024Stockholders may elect to redeem shares of Class A Common Stock until 5:00 pm Eastern Time, August 9, 2024 NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ:CVII), a special purpose acquisition company, announced today that the deadline for Churchill VII stockholders to elect redemption of their shares of class A common stock of Churchill VII ("Class A Common Stock") in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the "Business Combination") is extended until 5:00 P.M., Eastern Time on August 9, 2024. The redemption deadline is being extended so that stockholders will have sufficie
- SECChurchill Capital Corp VII filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits, Entry into a Material Definitive Agreement8-K - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- PRCorpAcq and Churchill Capital Corp VII Provide an Update on Proposed Financing to Support Business CombinationExpected Financing Would De-Risk Closing of Business Combination and is Anticipated to Support CorpAcq's Future Growth NEW YORK and ALTRINCHAM, England, Aug. 2, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill Capital Corp VII ("Churchill VII") (NASDAQ:CVII), a special purpose acquisition company, today provided an update on planned equity or equity-linked financing in support of the previously announced business combination (the "Business Combination") between CorpAcq, CorpAcq Group Plc, a public limited company incorporated under the laws of England and Wales and an
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- SECChurchill Capital Corp VII filed SEC Form 8-K: Other Events, Entry into a Material Definitive Agreement8-K - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- PRSpecial Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment to be Adjourned and Reconvened for August 12, 2024Redemption deadline for stockholders moved to August 8, 2024 NEW YORK, July 18, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it intends to adjourn each of the special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") and the meeting of Churchill VII warrant holders (the "Warrant Holder Meeting"), which are currently scheduled for July 25, 2024, to be held in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the "Business Combination"). The Stockholder Special Meeting will reconvene on August 12, 2024 at 10:0
- PRSpecial Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024Board of Directors Recommends Stockholders and Public Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England, June 20, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") to be held in connection with the proposed business combination (the "Business Combination") between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII and a meeting of Churchill VII public warrant holders (the "
- SECSEC Form DEFM14A filed by Churchill Capital Corp VIIDEFM14A - Churchill Capital Corp VII (0001828248) (Filer)
- SECSEC Form DEFA14A filed by Churchill Capital Corp VIIDEFA14A - Churchill Capital Corp VII (0001828248) (Filer)
- SECChurchill Capital Corp VII filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Entry into a Material Definitive Agreement8-K - Churchill Capital Corp VII (0001828248) (Filer)
CVII FAQ
5 questionsWhat does Churchill Capital Corp VII do?
Churchill Capital Corp VII focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.Where does CVII stock trade?
Churchill Capital Corp VII (CVII) is listed on NYSE.What sector and industry is CVII in?
Churchill Capital Corp VII operates in the Finance sector, Blank Checks industry.What companies are similar to CVII?
Notable peers in the same industry include JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.), PNTM (Pontem Corporation). Compare CVII side-by-side with any of them on Quantisnow.How can I track CVII on Quantisnow?
Quantisnow aggregates Churchill Capital Corp VII's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CVII to receive live email and push alerts on every new disclosure.